CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.99 ($49,900)
- 4 Open-market buy Chief Operating Officer bought 10,000 shares at $4.99 ($49,900)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $4.99 ($24,950)
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Other events
- S-1 Offering Registration Statement
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Other events
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
Page 4 of 61 · 1,218 filings